Company / Current Assets
Vivos Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$4.4M
FY2025
5-year range
$4.4M / $27.3M
FY2021-FY2025
Trend
-41.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $5M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -26.5%.
Declined from $5M to $4M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -6.8%
- 5-Year CAGR
- -26.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -26.5%, indicating a declining trend.
- In FY2025, current assets decreased 41.3% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.4M | -41.3% |
| FY2024 | $7.5M | +37.8% |
| FY2023 | $5.4M | +0.0% |
| FY2022 | $5.4M | -80.1% |
| FY2021 | $27.3M | +34.0% |
| FY2020 | $20.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026